What do the von Willebrand factor panel results—Factor VIII activity 50% (reference 50‑180%), von Willebrand factor antigen 66% (reference 50‑217%), ristocetin cofactor activity 70% (reference 42‑200%), and activated partial thromboplastin time 29 seconds (reference 23‑32 seconds)—indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Your von Willebrand Factor Panel Results Are Normal

These results indicate you do not have von Willebrand disease (VWD) based on current diagnostic criteria. All values fall within normal reference ranges, and the critical diagnostic ratios are preserved 1.

Understanding Your Results

Your test panel shows:

  • Factor VIII activity: 50% (normal range 50-180%)
  • VWF antigen: 66% (normal range 50-217%)
  • Ristocetin cofactor activity: 70% (normal range 42-200%)
  • aPTT: 29 seconds (normal range 23-32 seconds)

Why These Results Are Normal

The VWF:RCo/VWF:Ag ratio is the key diagnostic metric. Your ratio is approximately 1.06 (70/66), which is well above the diagnostic threshold of 0.5-0.7 used to distinguish normal from type 2 VWD variants 1. A ratio >0.7 indicates normal VWF function relative to quantity.

All individual values exceed the diagnostic cutoff for VWD. The established threshold for definite VWD diagnosis is <30% for both VWF:RCo and VWF:Ag 1. Your values of 70% and 66% are more than double this cutoff.

Your Factor VIII level, while at the lower end of normal, is not diagnostic of VWD. Factor VIII of 50% is within the normal range (50-200%) 1. In VWD, Factor VIII is typically reduced because VWF normally protects Factor VIII from degradation, but your preserved VWF levels adequately support Factor VIII.

Important Context About "Low-Normal" Values

Blood type O individuals naturally have VWF levels 25% lower than non-O blood types 1. If you have type O blood, your values would be considered even more reassuringly normal when adjusted for this physiological variation.

These tests have inherent variability (coefficient of variation 10-30%), particularly the ristocetin cofactor assay 1. Values near the lower reference range can fluctuate with repeat testing but remain clinically normal.

When to Consider Further Evaluation

If you have significant bleeding symptoms despite normal testing, repeat testing may be warranted 2, 1. VWD can show incomplete penetrance and variable expressivity, meaning some individuals with mild disease may have intermittently normal laboratory values.

Consider repeat testing if you experience:

  • Prolonged bleeding from minor cuts (>15 minutes)
  • Heavy menstrual bleeding requiring frequent pad/tampon changes
  • Easy bruising with minimal trauma
  • Excessive bleeding after dental procedures or surgery
  • Family history of diagnosed bleeding disorders

Screening tests like aPTT can be normal in mild VWD 2. Your normal aPTT of 29 seconds does not exclude mild disease if clinical suspicion is high, but combined with your normal VWF testing, it provides additional reassurance.

Clinical Bottom Line

No treatment or specific precautions are needed based on these results. Your hemostatic system appears to function normally. If you undergo surgery or invasive procedures, standard perioperative management is appropriate without special hemostatic interventions.

The combination of normal VWF activity, normal VWF antigen, preserved activity/antigen ratio >0.7, and normal aPTT effectively rules out clinically significant VWD 2, 1.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.